Comparison of In Vitro Susceptibility between 7:1 and 4:1 Mixtures of Amoxicillin and Clavulanate against Major Clinically-isolated Bacteria
Original article PDF Jongyoun Yi1, Jae-Kyoo Lee2, Eun-Joung Lee2 and Eui-Chong Kim1, 2 Department of Laboratory Medicine1, Seoul National University College of Medicine;Clinical Research Institute2, Seoul National University Hospital, Seoul, Korea Corresponding to Eui-Chong Kim, E-mail: euichong@snu.ac.kr Ann Clin Microbiol 2003;6(2):109-113.Copyright © Korean Society of Clinical Microbiology. Abstract Background : Amoxicillin/clavulanate (A/C) is a combination of a broad spectrum β-lactam antibiotic amoxicillin and the potent β-lactamase inhibitor clavulanate. A/C 7:1 combination is known to be equal in its clinical efficacy and to have less gastrointestinal adverse effects compared to conventional A/C 4:1 combination. We estimated in vitro antimicrobial activities of the 7:1 combination (AMOCLA Duo) and the conventional 4:1 combination against clinical bacterial isolates known to be the major causes of acute otitis media or sinusitis. Methods : Total 183 strains isolated from clinical specimens of patients at Seoul National University Hospital were tested for minimal inhibitory concentraion (MIC). Streptococcus pneumoniae and Haemophilus influenzae were tested by
